@article{oai:repo.qst.go.jp:00049225,
 author = {Li, Huizi and Sugyo, Aya and Tsuji, Atsushi and Morokoshi, Yukie and Minegishi, Katsuyuki and Nagatsu, Kotaro and Kanda, Hiroaki and Harada, Yosuke and Nagayama, Satoshi and Katagiri, Toyomasa and Nakamura, Yusuke and Higashi, Tatsuya and Hasegawa, Sumitaka and Li, Huizi and Aya, Sugyo and Atsushi, Tsuji and Yukie, Morokoshi and Katsuyuki, Minegishi and Kotaro, Nagatsu and Tatsuya, Higashi and Sumitaka, Hasegawa},
 issue = {7},
 journal = {Cancer Science},
 month = {Jun},
 note = {Synovial sarcoma (SS) is a rare yet refractory soft-tissue sarcoma that predominantly affects young adults. We show in a mouse model that radioimmunotherapy (RIT) with an α-particle emitting anti-Frizzled homolog 10 (FZD10) antibody, synthesized using the α-emitter radionuclide astatine-211 (211At-OTSA101), suppresses the growth of SS xenografts more efficiently than the corresponding β-particle emitting anti-FZD10 antibody conjugated with the β-emitter yettrium-90 (90Y-OTSA101). In biodistribution analysis, 211At was increased in the SS xenografts but decreased in other tissues up to 1 day after injection as time proceeded, albeit with a relatively higher uptake in the stomach. Single 211At-OTSA101 doses of 25 and 50 μCi significantly suppressed SS tumor growth in vivo, whereas a 50 μCi dose of 90Y-OTSA101 was needed to achieve this. Importantly, 50 μCi of 211At-OTSA101 suppressed tumor growth immediately after injection, whereas this effect required several days in the case of 90Y-OTSA101. Both radiolabeled antibodies at the 50 μCi dosage level significantly prolonged survival. Histopathologically, severe cellular damage accompanied by massive cell death was evident in the SS xenografts at even 1 day after the 211At-OTSA101 injection but these effects were relatively milder with 90Y-OTSA101 at the same timepoint, even though the absorbed doses were comparable (3.3 and 3.0 Gy, respectively). We conclude that α-particle RIT with 211At-OTSA101 is a potential new therapeutic option for SS.},
 pages = {2302--2309},
 title = {α-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10},
 volume = {109},
 year = {2020}
}